Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

ERJ open research·2026
Same author

Walking Uphill Aggravates Dyspnea and Dynamic Hyperinflation at Equivalent Oxygen Uptake in COPD Patients.

Journal of clinical medicine·2026
Same author

Asthma in Active Military Aircrew: Long-term Health and Flight Performance.

The Israel Medical Association journal : IMAJ·2026
Same author

Diagnostic Yield of EBUS Mediastinal Cryobiopsy Versus TBNA in Suspected Lymphoproliferative Disorders: A Prospective Multicentre Study.

Respirology (Carlton, Vic.)·2026
Same author

Safety and Feasibility of an Asynchronous AI-Integrated Tele-Pulmonary Rehabilitation Application Among Patients with COPD.

International journal of chronic obstructive pulmonary disease·2026
Same author

Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry.

Advances in therapy·2026

Related Experiment Video

Updated: Jan 11, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K

Interstitial Lung Diseases in Israel: Large Variability in Close Geographic Proximity.

Tzlil Hershko1,2, Ophir Freund1,2, Sonia Schneer3

  • 1Institute of Pulmonary Medicine, Tel Aviv Sourasky Medical Center, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6423906, Israel.

Diagnostics (Basel, Switzerland)
|November 13, 2025
PubMed
Summary

Interstitial lung diseases (ILD) show regional disparities in Israel. Peripheral areas have more Idiopathic Pulmonary Fibrosis (IPF), while central areas see more exposure-related and autoimmune ILD.

Keywords:
diagnosisidiopathic pulmonary fibrosisinterstitial lung diseasespulmonary fibrosisregistry

More Related Videos

Selective Harvesting of Marginating-pulmonary Leukocytes
07:06

Selective Harvesting of Marginating-pulmonary Leukocytes

Published on: March 11, 2016

6.2K
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.8K

Related Experiment Videos

Last Updated: Jan 11, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Selective Harvesting of Marginating-pulmonary Leukocytes
07:06

Selective Harvesting of Marginating-pulmonary Leukocytes

Published on: March 11, 2016

6.2K
A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation
08:46

A Standardized Method for Measuring Internal Lung Surface Area via Mouse Pneumonectomy and Prosthesis Implantation

Published on: July 26, 2017

13.8K

Area of Science:

  • Pulmonology
  • Epidemiology
  • Public Health

Background:

  • No prior comprehensive reports on interstitial lung diseases (ILD) in the Israeli population exist.
  • Potential for unique epidemiological features in Israel necessitates investigation.
  • Focus on regional disparities within Israel for ILD prevalence and characteristics.

Purpose of the Study:

  • To explore the epidemiology of ILD in Israel.
  • To identify and analyze regional variations in ILD diagnoses and patient demographics.
  • To investigate the association between geographic residence and ILD subtypes.

Main Methods:

  • Retrospective analysis of consecutive ILD patients from four tertiary medical centers in Israel.
  • Multidisciplinary diagnosis of ILD.
  • Multivariate regression models to assess the impact of residence (peripheral vs. central) on ILD subtypes.

Main Results:

  • 927 ILD patients included (mean age 67, 40% female).
  • Significant variations in demographics, exposures, and diagnoses observed between centers despite proximity.
  • Idiopathic Pulmonary Fibrosis (IPF) more common in peripheral areas (53% vs. 24%), while exposure-related and autoimmune ILD more frequent in central areas (16% vs. 5% and 25% vs. 16%, respectively).
  • Peripheral residence independently predicted IPF (AOR 2.95); central residence predicted exposure-related ILD (AOR 0.46).

Conclusions:

  • Significant regional disparities in ILD characteristics exist within Israel.
  • Peripheral residence is a predictor for IPF, while central residence is linked to exposure-related ILD.
  • Personalized ILD assessment is crucial, considering local frequencies and environmental exposures.